The glymphatic system: a new perspective on brain diseases
Z Ding, X Fan, Y Zhang, M Yao, G Wang… - Frontiers in Aging …, 2023 - frontiersin.org
The glymphatic system is a brain-wide perivascular pathway driven by aquaporin-4 on the
endfeet of astrocytes, which can deliver nutrients and active substances to the brain …
endfeet of astrocytes, which can deliver nutrients and active substances to the brain …
[HTML][HTML] The inflammatory puzzle: piecing together the links between neuroinflammation and amyotrophic lateral sclerosis
D He, Y Xu, M Liu, L Cui - Aging and Disease, 2024 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that has a complex
genetic basis. Through advancements in genetic screening, researchers have identified …
genetic basis. Through advancements in genetic screening, researchers have identified …
The Node of Ranvier as an Interface for Axo-Glial Interactions: Perturbation of Axo-Glial Interactions in Various Neurological Disorders
The action potential conduction along the axon is highly dependent on the healthy
interactions between the axon and myelin-producing glial cells. Myelin, which facilitates …
interactions between the axon and myelin-producing glial cells. Myelin, which facilitates …
CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
Y Shi, Y Zhao, L Lu, Q Gao, D Yu, M Sun - Frontiers in Neuroscience, 2023 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a deadly neurological disease with a complicated and
variable pathophysiology yet to be fully understood. There is currently no effective treatment …
variable pathophysiology yet to be fully understood. There is currently no effective treatment …
Rare DNAJC7 Variants May Play a Minor Role in Chinese Patients with ALS
S Wang, X Zheng, Q Wei, J Lin, T Yang, Y Xiao… - Molecular …, 2024 - Springer
DnaJ heat shock protein family member C7 gene (DNAJC7) has been identified as a genetic
risk factor for amyotrophic lateral sclerosis (ALS). In our study, we aimed to screen for rare …
risk factor for amyotrophic lateral sclerosis (ALS). In our study, we aimed to screen for rare …
Fetal Therapies–(stem cell transplantation; enzyme replacement therapy; in utero genetic therapies)
R Sagar, AL David - Best Practice & Research Clinical Obstetrics & …, 2024 - Elsevier
Advances in ultrasound and prenatal diagnosis are leading an expansion in the options for
parents whose fetus is identified with a congenital disease. Obstetric diseases such as pre …
parents whose fetus is identified with a congenital disease. Obstetric diseases such as pre …
Translating the ALS Genetic Revolution into Therapies: A Review
C Meadows, NA Rau, W Faridi, CV Ly - Current Treatment Options in …, 2024 - Springer
Abstract Purpose of Review Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
disease causing weakness, respiratory failure, and death within 3 to 5 years. Approximately …
disease causing weakness, respiratory failure, and death within 3 to 5 years. Approximately …
Current neuroprotective therapies and future prospects for motor neuron disease.
LJ Evans, D O'Brien, PJ Shaw - International Review of …, 2024 - europepmc.org
Four medications with neuroprotective disease-modifying effects are now in use for motor
neuron disease (MND). With FDA approvals for tofersen, relyvrio and edaravone in just the …
neuron disease (MND). With FDA approvals for tofersen, relyvrio and edaravone in just the …
Rare diseases, spotlighting amyotrophic lateral sclerosis, Huntington's disease, and myasthenia gravis: Insights from landscape analysis of current research
Rare diseases are a diverse group of disorders that despite each individual condition's
rarity, collectively affect a significant portion of the global population. Currently …
rarity, collectively affect a significant portion of the global population. Currently …
Rare diseases: Insights from landscape analysis of current research, spotlighting amyotrophic lateral sclerosis, Huntington's disease, and myasthenia gravis
Rare diseases are a diverse group of disorders that despite each individual condition's
rarity, collectively affect a significant portion of the global population. Currently …
rarity, collectively affect a significant portion of the global population. Currently …